loader
Please Wait
Applying Filters...

EuroAPI Header EuroAPI Header

X

List of Certificates of Suitability (CEPs) for r0_cep_2015_139___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 CIPLA LIMITED Mumbai IN (1)

filter

01 Sertraline hydrochloride (1)

filter

01 India (1)

filter

01 Withdrawn by Holder (1)

URL Supplier Web Content
R0-CEP 2015-139 - Rev 01
Withdrawn by Holder
Chemical
2018-07-09
2022-03-14
1705
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R0-CEP 2015-139 - Rev 01 of Cipla Limited Mumbai In

Looking for Certificates of Suitability (CEPs) for R0-CEP 2015-139 - Rev 01 of Cipla Limited Mumbai In 1

20

Cipla Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their significant offerings is Sertraline hydrochloride, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2015-139 - Rev 01

This Chemical Type CEP, issued on July 09, 2018, remains in force until March 14, 2022, ensuring its reliability within the pharmaceutical industry.

Substance Number 1705 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY